Home Page News Opinion Foreign Policy Politics Policy Legislation Lobbying Hill Life & People Hill Climbers Heard On The Hill Calendar Archives Classifieds
Hill Times Events Inside Ottawa Directory Hill Times Books Hill Times Careers The Wire Report The Lobby Monitor Parliament Now
Subscribe Free Trial Reuse & Permissions Advertising
Log In
Policy Briefing: Biotechnology

‘Everyone wants what Canada has,’ says leading biotechnology industry association

A 2011 report by BIOTECanada says the current Canadian bioeconomy, valued at $86.5-billion in 2010, represents seven per cent of national GDP.
Observers say Canada’s intellectual property regime needs to extend protections on R&D data to compete globally.
Industry association looks to feds, the central player in facilitating access to capital.
The current federal government boasts of being a ‘strong stable majority’ government, but its record on stable policies to nurture growth in important economic sectors, such as biotechnology, has not been good.
Inter-provincial Life Sciences Corridor seeks to brand one of the world’s largest biotech clusters.

Industry insiders say the government needs senior leadership when it comes to science and technology.
Analysts say its time for industry and government to come up with creative solutions to attract venture capital and experienced execs.

Your group subscription includes premium access to Politics This Morning briefing.